Google
Trusted Resources: News & Events
Latest announcements and gatherings
APS Scientific Meeting 2019
The American Pain Society will hold its Scientific Meeting April 3-6, 2019, in Milwaukee, WI, with a balance of clinical, translational, and basic science research around the theme of Combating the Opioid Epidemic through Innovations in the Treatment of Pain. This year, APS is excited to introduce new presentation types. Sessions will either be 60-minute cross-disciplinary panels, or rapid 30-minute presentations that showcase the latest research.
What to expect at the 2019 APS Meeting:
• Women in Leadership panel are back!
• Intimate space – All sessions, exhibits, and posters will be held on one floor
• SIGs within the schedule – SIGs are invited to connect their meeting to the theme combating the Opioid Epidemic through Innovations in the Treatment of Pain
• Formal networking and collaboration opportunities
• Popular preconference events return – Early Career Forum, Spring Pain, and Fundamentals Course
Location:
Wisconsin Center
400 W Wisconsin Ave
Milwaukee, Wisconsin, United States
This event has ended.
+myBinderRelated Content
-
Characteristics of a Chronic Pain Phenotype in Adults with Sickle Cell DiseaseSickle cell disease (SCD) is characteriz...
-
Methadone provides pain relief for kids with sickle cellMany children with sickle cell disease e...
-
Dyspareunia is Associated With Chronic Pain in Premenopausal Women With Sickle Cell DiseaseObjectives: Pain is common in women wit...
-
How sickled red blood cells stick to blood vesselsOne of the most common complications o...
-
Long-term opioids may not be best pain management option for all sickle cell patientsSmall study shows some on opioids report...
-
Crizanlizumab designated FDA breakthrough therapy for potential in vaso-occlusive crisis preventionCrizanlizumab (SEG101), Novartis‘ inve...
-
Study Confirms Safe Use of Opioids for Pain Control in Sickle Cell DiseaseThe most common cause of hospital admiss...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.